Our EoE Team is Ready
Hello and welcome to our Food Additive Removal Trial for Eosinophilic Esophagitis (FREoE) in Children and Teens!
My background is that I was trained in general pediatrics and pediatric gastroenterology at the Children’s Hospital of Philadelphia. I am currently in sunny Orlando, Florida at Nemours Children’s Hospital and serve as the Division Chief for the Division of Gastroenterology, Hepatology and Nutrition. I have had the privilege to care for patients with EoE for over 12 years.
Our team has been fortunate to bring many advances to the field of pediatric EoE with over 60 peer reviewed publications. A focus on children, teens and families has always been at top of mind, with the development of the first and only patient/family validated outcome metrics called the PedsQLEoE module and the Pediatric Eosinophilic Esophagitis (EoE) Score (PEES™ v2.0).
We believe this clinical trial is an important step forward. There is increasing concern by the Food and Drug Administration, the American Academy of Pediatrics and within the field of Pediatric GI that food additives may be contributing to inflammation in the body. Our FREoE study seeks to determine whether food additives and preservatives many play a role in EoE. Overall, we look to provide either a dairy or dairy plus food additive removal diet that is healthy and manageable in everyone’s busy daily lives. We will have the unique ability to provide nutrition support and study enrollment remotely.
James P. Franciosi M.D., M.S., M.S.C.E., F.A.A.P.
Chief, Division of Gastroenterology, Hepatology and Nutrition